QUANTIFYING THE HEALTH ECONOMIC BENEFIT OF KEY THERAPEUTIC OUTCOMES IN THE MANAGEMENT OF TYPE 2 DIABETES AND ASSESSING THEIR INTER-RELATIONAHIP
Abstract
Authors
P. McEwan V. Foos M. Lamotte M. Evans
P. McEwan V. Foos M. Lamotte M. Evans
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now